LV12047B - CONDENSED PIRIMIDINE DERIVATIVES AND THEIR USE OF ANGIOTENZINE II ANTAGONISTS - Google Patents

CONDENSED PIRIMIDINE DERIVATIVES AND THEIR USE OF ANGIOTENZINE II ANTAGONISTS Download PDF

Info

Publication number
LV12047B
LV12047B LVP-98-45A LV980045A LV12047B LV 12047 B LV12047 B LV 12047B LV 980045 A LV980045 A LV 980045A LV 12047 B LV12047 B LV 12047B
Authority
LV
Latvia
Prior art keywords
formula
compound
methyl
pharmaceutically acceptable
tetrazol
Prior art date
Application number
LVP-98-45A
Other languages
English (en)
Latvian (lv)
Other versions
LV12047A (lv
Inventor
John Watson Ellingboe
Madelene Nikaido
Jehan Franroz Bagli
Original Assignee
American Home Products Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/782,025 external-priority patent/US5149699A/en
Priority claimed from GB9207560A external-priority patent/GB2265899A/en
Priority claimed from US07/901,485 external-priority patent/US5256654A/en
Application filed by American Home Products Corporation filed Critical American Home Products Corporation
Publication of LV12047A publication Critical patent/LV12047A/xx
Publication of LV12047B publication Critical patent/LV12047B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LVP-98-45A 1991-10-24 1998-03-09 CONDENSED PIRIMIDINE DERIVATIVES AND THEIR USE OF ANGIOTENZINE II ANTAGONISTS LV12047B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/782,025 US5149699A (en) 1991-10-24 1991-10-24 Substituted pyridopyrimidines useful as antgiotensin II antagonists
GB9207560A GB2265899A (en) 1992-04-07 1992-04-07 Substituted pyrimidines
US07/901,485 US5256654A (en) 1991-10-24 1992-06-25 Substituted pyrrolopyrimidines, azepinopyrimidines and pyridopyrimidines useful as angiotensin II antagonists

Publications (2)

Publication Number Publication Date
LV12047A LV12047A (lv) 1998-05-20
LV12047B true LV12047B (en) 1998-08-20

Family

ID=27266132

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-98-45A LV12047B (en) 1991-10-24 1998-03-09 CONDENSED PIRIMIDINE DERIVATIVES AND THEIR USE OF ANGIOTENZINE II ANTAGONISTS

Country Status (21)

Country Link
EP (1) EP0539086B1 (no)
JP (1) JP3240192B2 (no)
KR (1) KR100286624B1 (no)
CN (2) CN1039324C (no)
AT (1) ATE161537T1 (no)
AU (1) AU653635B2 (no)
CA (1) CA2080705C (no)
DE (1) DE69223734T2 (no)
DK (1) DK0539086T3 (no)
ES (1) ES2111617T3 (no)
FI (1) FI103971B (no)
GR (1) GR3025926T3 (no)
HK (1) HK1003031A1 (no)
HU (2) HU218786B (no)
IL (1) IL103436A (no)
LV (1) LV12047B (no)
NO (1) NO301275B1 (no)
SG (1) SG47626A1 (no)
SK (1) SK322192A3 (no)
TW (1) TW226375B (no)
UA (1) UA27748C2 (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK280887B6 (sk) * 1991-11-18 2000-09-12 E. I. Du Pont De Nemours And Company Spôsob výroby tetrazolylbifenylových zlúčenín a medziprodukty tohto spôsobu
EP0863143A1 (en) * 1993-03-24 1998-09-09 American Home Products Corporation Intermediates useful in the production of pyridopyrimidone angiotensin AII antagonists
ATE176784T1 (de) * 1994-09-20 1999-03-15 Wakunaga Seiyaku Kk Verfahren zur herstellung von n- biphenylmethylthiadiazolin derivaten oder deren salzen sowie dafür benötigte zwischen verbindungen
IT1292437B1 (it) * 1997-06-30 1999-02-08 Zambon Spa Processo di orto-metallazione utile per la sintesi di 1 - tetrazol- 5-il) benzeni 2-sostituiti
US6638937B2 (en) 1998-07-06 2003-10-28 Bristol-Myers Squibb Co. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
PE20020617A1 (es) 2000-08-22 2002-08-05 Novartis Ag Composicion que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina o un sensibilizante a la insulina
US8168616B1 (en) 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
GB0327839D0 (en) 2003-12-01 2003-12-31 Novartis Ag Organic compounds
GB0402262D0 (en) 2004-02-02 2004-03-10 Novartis Ag Process for the manufacture of organic compounds
CA2558020A1 (en) 2004-03-17 2005-09-29 Novartis Ag Use of renin inhibitors in therapy
PT1799199E (pt) 2004-10-08 2012-07-03 Novartis Ag Uso de inibidores da renina para a prevenção ou tratamento da disfunção diastólica ou insuficiência cardíaca diastólica
EP1749828A1 (en) 2005-08-04 2007-02-07 Farmaprojects S.L. Process for preparing an angiotensin II receptor antagonist
NZ579310A (en) 2007-03-01 2012-03-30 Probiodrug Ag Use of glutaminyl cyclase inhibitors for the treatment of mild cognitive impairment and diagnostic purposes thereof
DK2142514T3 (da) 2007-04-18 2015-03-23 Probiodrug Ag Thioureaderivater som glutaminylcyclase-inhibitorer
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EA020466B1 (ru) 2007-06-04 2014-11-28 Синерджи Фармасьютикалз Инк. Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
BRPI0812775B8 (pt) * 2007-06-07 2021-05-25 Alfasigma Spa uso de 17 beta-(3-furil)-5 beta-androstano-3 beta, 14 beta, 17 alfa- triol na preparação de um medicamento para prevenção ou tratamento de doenças devidas à fibrose hepática
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US8486940B2 (en) 2009-09-11 2013-07-16 Probiodrug Ag Inhibitors
EP2542549B1 (en) 2010-03-03 2016-05-11 Probiodrug AG Inhibitors of glutaminyl cyclase
BR112012022478B1 (pt) 2010-03-10 2021-09-21 Probiodrug Ag Inibidores heterocíclicos de glutaminil ciclase (qc, ec 2.3.2.5), seu processo de preparação, e composição farmacêutica
US8541596B2 (en) 2010-04-21 2013-09-24 Probiodrug Ag Inhibitors
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US8530670B2 (en) 2011-03-16 2013-09-10 Probiodrug Ag Inhibitors
WO2013090196A1 (en) 2011-12-15 2013-06-20 Takeda Pharmaceuticals U.S.A., Inc. Combinations of azilsartan and chlorthalidone for treating hypertension black patients
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
PT3004138T (pt) 2013-06-05 2024-06-18 Bausch Health Ireland Ltd Agonistas ultrapuros de guanilato ciclase c, método de produção e utilização dos mesmos
ES2812698T3 (es) 2017-09-29 2021-03-18 Probiodrug Ag Inhibidores de glutaminil ciclasa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0407342A3 (en) * 1989-07-06 1991-07-10 Ciba-Geigy Ag Pyrimidine derivatives
US5100897A (en) * 1989-08-28 1992-03-31 Merck & Co., Inc. Substituted pyrimidinones as angiotensin ii antagonists
EP0415886A3 (en) * 1989-08-30 1991-10-23 Ciba-Geigy Ag Aza compounds
JPH05504969A (ja) * 1990-02-13 1993-07-29 メルク・エンド・カムパニー・インコーポレーテツド 置換ベンジル要素を含有するアンギオテンシン２アンタゴニスト類
US5149699A (en) * 1991-10-24 1992-09-22 American Home Products Corporation Substituted pyridopyrimidines useful as antgiotensin II antagonists

Also Published As

Publication number Publication date
CN1175414A (zh) 1998-03-11
NO924121L (no) 1993-04-26
UA27748C2 (uk) 2000-10-16
CN1039324C (zh) 1998-07-29
EP0539086A3 (en) 1993-06-16
DE69223734T2 (de) 1998-04-16
DE69223734D1 (de) 1998-02-05
EP0539086A2 (en) 1993-04-28
HU9203161D0 (en) 1992-12-28
FI924397A0 (fi) 1992-09-30
NO924121D0 (no) 1992-10-23
AU653635B2 (en) 1994-10-06
DK0539086T3 (da) 1998-02-02
CA2080705C (en) 2002-12-03
KR100286624B1 (ko) 2001-05-02
NO301275B1 (no) 1997-10-06
CN1072682A (zh) 1993-06-02
HUT62893A (en) 1993-06-28
FI924397A (fi) 1993-04-25
FI103971B1 (fi) 1999-10-29
FI103971B (fi) 1999-10-29
IL103436A0 (en) 1993-03-15
LV12047A (lv) 1998-05-20
HU218786B (hu) 2000-12-28
AU2607992A (en) 1993-04-29
JPH05222039A (ja) 1993-08-31
IL103436A (en) 1996-03-31
ATE161537T1 (de) 1998-01-15
SK280292B6 (sk) 1999-11-08
HK1003031A1 (en) 1998-09-30
CA2080705A1 (en) 1993-04-25
HU211915A9 (en) 1996-01-29
EP0539086B1 (en) 1997-12-29
JP3240192B2 (ja) 2001-12-17
SK322192A3 (en) 1999-11-08
TW226375B (no) 1994-07-11
KR930007949A (ko) 1993-05-20
GR3025926T3 (en) 1998-04-30
SG47626A1 (en) 1998-04-17
ES2111617T3 (es) 1998-03-16

Similar Documents

Publication Publication Date Title
LV12047B (en) CONDENSED PIRIMIDINE DERIVATIVES AND THEIR USE OF ANGIOTENZINE II ANTAGONISTS
US5149699A (en) Substituted pyridopyrimidines useful as antgiotensin II antagonists
JP3260415B2 (ja) アンギオテンシンｉｉ拮抗作用を有する複素環化合物
EP0611368B1 (en) Substituted aminopyrimidines as angiotensin ii antagonists
US5466692A (en) Substituted pyridopyrimidines and antihypertensives
EP0612317A1 (en) Substituted heterocycles as angiotensin ii antagonists
US5330989A (en) Heterocycles substituted with biphenyl-3-cyclobutene-1,2-dione derivatives
US5283242A (en) Substituted benzimidazoles and quinazolines as antihypertensives
TW202136236A (zh) Adamts抑制劑、其製備方法及醫藥用途
US5256654A (en) Substituted pyrrolopyrimidines, azepinopyrimidines and pyridopyrimidines useful as angiotensin II antagonists
EP0618207B1 (en) Substituted pyridopyrimidines as antihypertensives
JP2000063275A (ja) 医薬組成物
GB2265899A (en) Substituted pyrimidines
US6096754A (en) N-3 substituted pyrimidin-4-ones with AII antagonistic activity